What Strateos does

Strateos automates chemistry, biology, and tissue analysis into closed-loop robotic labs that accelerate drug discovery programs. Through a combination of best-in-class robotics and control systems, advanced software for imaging and analytics, and remote cloud laboratories, they enable pharmaceutical partners to more rapidly and efficiently discover new drug candidates. Born of a merger between Transcriptic and 3Scan, Strateos combines the strengths of those companies to amplify their impact and accelerate drug discovery. Transcriptic developed the first robotic cloud laboratory platform for on-demand life science research, which is currently in use at several top pharmaceutical and biotechnology companies. 3Scan combined automation, machine learning and computer vision to extract spatial data from tissue samples and create detailed 3D representations as well as quantitative analysis of complex anatomical structures. Now these two portfolios will be combined to offer a suite of technologies for accelerating drug discovery and early development. By expressing life science methods as data, infrastructure virtualization will become possible. "Science-as-a-Service" will power the next generation of discovery, driven by huge efficiencies of both time and money. Transcriptic was founded in 2012 to create a better way to get lab work done. Tired of spending endless hours at the bench pretending to be slow, error-prone robots, they set out to build a modern solution to the day-to-day process of wet lab biology. Drawing on deep computer science and electrical engineering backgrounds in addition to life science, Strateos was born: a meticulously optimized, technology-enabled remote lab. Using state-of-the-art automation and control technology, and an emphasis on user experience and usability, they are working on building a stark contrast to the long, complicated sales process, high prices, and slow turnarounds of traditional CROs. They are working hard to build a great company that can be a true partner for your lab for a long time, progressively enabling ever greater levels of productivity and efficiency. They are scientists building for scientists.

Name

Strateos

Legal name

Strateos, Inc.

Website

http://www.strateos.com

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

101–250 employees

Short description

Strateos is a SaaS-based biotechnology company that provides robotic solutions for biology labs.

Ownership category

akta.pro rank

Product category

Cloud Lab Automation Software

NAICS

Analytical Laboratory Instrument Manufacturing (334516), Computer Systems Design and Related Services (54151)

SIC

Laboratory Analytical Instruments (3826), Services-Prepackaged Software (7372)

akta.pro primary industry

Lab Automation, Instrument Control & Workflow Orchestration Software (HLAGAJAG)

akta.pro secondary industries

Liquid Handling & Laboratory Automation (Pipettes, Robots, Workstations) (HLAGAIAD), Lab Middleware, Instrument Connectivity & Automation (HLACAMAI), AI/ML Platforms for Drug Discovery & Experiment Optimization (HLAGAJAO)

Keywords

• Cloud lab automation
• Drug discovery services
• High throughput screening
• Lab robotics platform
• Biotech SaaS solutions

Headquarters

HQ city

Menlo Park

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Infrastructure, Operations, Marketing or Sales

Revenue model

1. Cloud Lab Automation Services: Subscription and usage-based access to remote-controlled robotic cloud labs. Scientists pay for experiment execution, automation module access, and data generation services. Pricing based on protocol complexity, number of runs, and throughput requirements.
2. Lab Control Software Licensing: Enterprise software licensing for organizations to deploy Strateos Lab Control Software in their own facilities. Includes Protocol Request, Request Management, Data Acquisition, and Sample Tracking modules.
3. Professional Services: Custom assay development, project strategy guidance, implementation support, and training services for cloud lab and software deployments.
4. Smart Lab Design & Build Services: Consulting and implementation services for organizations building their own automated labs. Includes facility design, workcell integration, and software deployment.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels6 records

Core offering

Strateos operates the industry's first Cloud Lab Automation-as-a-Service Platform, providing remote-controlled robotic laboratories and proprietary lab control software. Through three delivery modes — Control Our Lab (remote access to Strateos-operated cloud labs in Menlo Park and San Diego), Control Your Lab (lab control software licensing for customer facilities), and Build Your Lab (custom automated lab design-build services) — the company enables scientists to design, run, and analyze scientific experiments remotely via web browser or API, supporting high-throughput screening, automated DMTA cycles, antibody discovery, and small molecule drug discovery workflows.

Product overview

Strateos offers a Cloud Lab Automation-as-a-Service Platform as its core product, with three main access modes: Control Our Lab (remote access to Strateos's robotic cloud labs), Control Your Lab (lab control software for organizations' own facilities), and Build Your Lab (design-build services for creating private automated facilities). The platform integrates specialized modules including AI for Drug Discovery, Antibody Discovery, Discovery Biology, and Small Molecule Drug Discovery (covering assay development, hit identification, hit-to-lead, lead optimization, medicinal chemistry, chemical libraries, synthetic biology, tissue technology, high content imaging, and automated DMTA cycles). The architecture combines high-throughput robotics, remote web browser access, secure APIs, and closed-loop automation to accelerate scientific discovery across pharma, biotech, startups, academia, and CROs.

Differentiator

Problem solved

Functional benefit

Brands

• SmartLab Platform: Cloud Lab Automation-as-a-Service Platform for remote scientific experimentation
• Strateos Lab Control Software
• SmartLab Studio

Products and services

• Strateos Cloud Lab Automation-as-a-Service Platform Industry-first Cloud Lab Automation-as-a-Service Platform that lets scientists worldwide design, run, and analyze experiments remotely via web browser using Strateos's robotic laboratories; combines high-throughput lab automation with proprietary control software for pharmaceutical, biotech, academic, and AI-first customers.
• Control Our Lab On-demand remote access to Strateos's robotic cloud labs in Menlo Park and San Diego; scientists orchestrate workflows virtually and command lab automation modules from anywhere in the world.
• Control Your Lab (Lab Control Software) Lab automation software that lets organizations control their own scientific instruments and laboratories locally and worldwide, schedule workflows, and manage scientific data; includes Protocol Request, Request Management, Data Acquisition, and Sample Tracking modules.
• Build Your Lab (Design & Build Services) Smart lab facility design-build services and lab control software that enable organizations to create their own automated facilities, including modular workcells and smart facility design, with the option to toggle between private labs and Strateos's remote-controlled robotic cloud labs.
• AI for Drug Discovery AI-powered drug discovery platform combining best-in-class robotics and control systems with advanced software for imaging and analytics to help pharmaceutical partners more rapidly discover new drug candidates.
• Antibody Discovery Automated antibody discovery workflows using optimized automation workcells, including molecular biology gene assembly (Golden Gate, NEBuilder), high-throughput screening, characterization, and validation via MSD multi-array technology and ELISA-based assays.
• Discovery Biology Integrative discovery biology services connecting remote R&D teams to Strateos's smart labs for on-demand access to molecular biology, protein expression, screening assays, and analytical workflows.
• Small Molecule Drug Discovery Integrated small molecule screening and drug discovery workflows encompassing assay development, hit identification, hit-to-lead, lead optimization, and automated medicinal chemistry for small molecule therapeutics.
• Chemical Libraries (500K and 50K) Diverse library of 500K ready-to-use compounds for high throughput screening, with a 50K diversity set; compounds filtered by Lipinski Rule of 5 and stored on-site at the San Diego facility for immediate use.
• Assay Onboarding and Development Custom development of biochemical, biophysical, and cell-based assays using industry-standard and innovative technologies, supporting target classes including GPCRs, kinases, ion channels, nuclear receptors, proteases, and protein-protein interactions.
• Hit Identification (High Throughput Screening) State-of-the-art fully automated robotic platform for biochemical, phenotypic, and cellular HTS assays in 384- or 1536-well formats, capable of screening up to 100,000 compounds per day.
• Hit-to-Lead and Lead Optimization Service that selects promising hits and leverages automated chemical synthesis workflows for faster experimental screening cycles, decreasing duration and hands-on time to reduce overall drug discovery timeline.
• Medicinal Chemistry Extensive medicinal chemistry capabilities including chemical synthesis, purification, and analysis via robotics and automation; reproducible and validated reactions using Buchwald, amide, and Suzuki reactions at 0.7 mmol scale.
• Synthetic Biology / Biofoundry

Quantifiable outcome

• 70% reduction in DMTA cycle time - 14 analog compounds completed in ~40 hours over 4 days versus 2 weeks for conventional CRO
• +4 more outcomes

Named customers5 records

Segments6 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

Yes

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

AI capability8 records

Feature8 records

Partnerships

One partnership is on record.

• University of WashingtonstrategicStrategic or Co-development PartnerAcademic research partnership where Strateos provides lab automation and robotics capabilities while researchers focus on AI-based protein design. Professor Philip Romero cited the partnership as enabling focus on computational work while leveraging Strateos automation expertise.

Scale indicators8 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Emerald Cloud Lab: Emerald Cloud Lab operates remote, robotic cloud laboratories that scientists can access via the web to run experiments on demand. It is the closest direct competitor to Strateos's 'Control Our Lab' offering, with similar positioning around fully automated, remotely orchestrated wet-lab workflows.
• Benchling: Benchling is a cloud-based R&D platform providing ELN, LIMS, and molecular biology workflow software widely used across biopharma. It is a direct peer in the life-science software stack that Strateos integrates with, and increasingly overlaps in laboratory data management and workflow orchestration.
• LabVantage Solutions: LabVantage provides LIMS and laboratory informatics software for regulated and research labs across pharma and biotech. Comparable as a peer in lab data management and instrument connectivity, areas where Strateos's 'Lab Control Software' competes or integrates.
• Arctoris: Arctoris offers automated, remotely operated biology experimentation as a service for drug discovery, including biochemical and cell-based assays. A direct peer in the cloud-delivered wet-lab experimentation category that competes for similar biotech and pharma discovery budgets.

Broad incumbents

• Tecan: Tecan is a leading manufacturer of laboratory automation instruments, liquid handling robotics, and workstations used in drug discovery and diagnostics. It represents the incumbent hardware layer that Strateos's cloud orchestration sits on top of, and a potential competitor if Tecan expands into software/cloud layers.
• Hamilton Company: Hamilton Robotics provides automated liquid handling workstations and lab robotic systems widely used in high-throughput screening. Comparable as an incumbent lab-automation vendor whose installed base Strateos both competes with and depends on as a hardware substrate.
• Thermo Fisher Scientific: Thermo Fisher is a global life-sciences tools and instrumentation incumbent spanning instruments, consumables, software (including LIMS/ELN), and CRO services. It is a broad incumbent whose instruments Strateos integrates (e.g., KingFisher Flex) and whose scale and breadth could pressure Strateos in either direction.
• PerkinElmer: PerkinElmer provides life-sciences instrumentation, software (including the Signals Notebook ELN integrated with Strateos), and diagnostic solutions. It is both an integration partner and a broad incumbent that competes for informatics and lab automation budgets.

Emerging players

• Ginkgo Bioworks: Ginkgo Bioworks operates a large-scale synthetic biology platform (its 'Foundry') combining robotics and automation for cell engineering. It overlaps with Strateos's synthetic biology and biofoundry offerings, particularly for AI-driven organism engineering customers.
• Automata Labs: Automata (and its open automation platform) builds integrated lab automation hardware and software for life-science workflows, with an emphasis on benchtop automation. It overlaps with Strateos on modular automation workcells and cloud-orchestrated lab workflows.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• GitHubgithub.com/strateos
• LinkedInlinkedin.com/company/strateos1
• Xx.com/strateoslab

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds10 records

Investors28 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Strateos